Literature DB >> 10459559

Dose-response relationship of insulin to glucose fluxes in the awake and unrestrained mouse.

H Q Shen1, J S Zhu, A D Baron.   

Abstract

The purpose of the study was to use the hyperinsulinemic-euglycemic clamp technique to generate insulin dose-response curves for insulin suppression of endogenous glucose output (EGO) and stimulation of the glucose disposal rate (GDR) in conscious unstressed mice. Five groups of male ICR (Institute for Cancer Research) mice were studied (N = 43). The animals underwent surgery for implantation of a jugular vein catheter 2 to 3 days before the clamp and were fasted 6 hours before the study. Each group was clamped at a different insulin infusion rate of 0, 2.5, 10, or 20 mU/kg/min. 3H-3-glucose was infused for measurement of the glucose turnover rate (rate of appearance [Ra]). Blood samples were collected by milking a severed tail-tip. EGO was calculated as the difference between the Ra and glucose infusion rate (GIR), and the glucose clearance rate (GCR) as the GDR divided by the plasma glucose concentration. From the curves generated, half-maximal EGO and GCR were obtained at a plasma insulin concentration of 20 to 30 microU/mL, which was achieved at an insulin infusion rate of about 4 to 5 mU/kg/min. Maximal suppression of EGO and stimulation of the GCR occurred at an insulin infusion rate of 10 mU/kg/min. The establishment of normative curves for insulin-stimulated glucose metabolism in conscious mice facilitates the evaluation of glucose metabolism in a variety of mouse models of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459559     DOI: 10.1016/s0026-0495(99)90191-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Insulin transport within skeletal muscle transverse tubule networks.

Authors:  P R Shorten; C D McMahon; T K Soboleva
Journal:  Biophys J       Date:  2007-07-13       Impact factor: 4.033

2.  Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo.

Authors:  Thiago M Batista; Ruben Garcia-Martin; Weikang Cai; Masahiro Konishi; Brian T O'Neill; Masaji Sakaguchi; Jong Hun Kim; Dae Young Jung; Jason K Kim; C Ronald Kahn
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

3.  Hepatic glucose sensing is required to preserve β cell glucose competence.

Authors:  Pascal Seyer; David Vallois; Carole Poitry-Yamate; Frédéric Schütz; Salima Metref; David Tarussio; Pierre Maechler; Bart Staels; Bernard Lanz; Rolf Grueter; Julie Decaris; Scott Turner; Anabela da Costa; Frédéric Preitner; Kaori Minehira; Marc Foretz; Bernard Thorens
Journal:  J Clin Invest       Date:  2013-03-15       Impact factor: 14.808

4.  Beta-arrestin-1 protein represses diet-induced obesity.

Authors:  Le-nan Zhuang; Wen-xiang Hu; Ming-liang Zhang; Shun-mei Xin; Wei-ping Jia; Jian Zhao; Gang Pei
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

5.  Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.

Authors:  Kaori Minehira; Stephen G Young; Claudio J Villanueva; Laxman Yetukuri; Matej Oresic; Mark K Hellerstein; Robert V Farese; Jay D Horton; Frederic Preitner; Bernard Thorens; Luc Tappy
Journal:  J Lipid Res       Date:  2008-06-01       Impact factor: 5.922

6.  Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance.

Authors:  Bing Luan; Jian Zhao; Haiya Wu; Baoyu Duan; Guangwen Shu; Xiaoying Wang; Dangsheng Li; Weiping Jia; Jiuhong Kang; Gang Pei
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962

7.  Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.

Authors:  Yiling Si; Yali Zhao; Haojie Hao; Jiejie Liu; Yelei Guo; Yiming Mu; Jing Shen; Yu Cheng; Xiaobing Fu; Weidong Han
Journal:  Diabetes       Date:  2012-06       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.